Seeking Alpha

Seeking Alpha Portfolio App for iPad

930 people get PRGO articles and Market Currents by email alert.

Get email alerts on PRGO »

PRGO

Perrigo Company

5/23/2013, 9:53 AM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 7, 11:39 AM Perrigo (PRGO -3.7%) takes a hit this morning after its FQ3 result misses across the board. Net earnings fell 3.3% Y/Y, as the pharmaceutical supplier was hit by higher input costs and a big jump in tax expenses, which masked a 19% increase in net sales. All product categories within the segment grew from the year earlier, with sales in the nutritionals business in particular rising 13% to $133.3M. Gross margin also edged up to 36% from 35.9%, despite total operating expenses widening by 15%. Comment! [Healthcare, Earnings, On the Move, Consumer]
Tuesday, May 7, 7:48 AM Perrigo (PRGO): Q1 EPS of $1.42 misses by $0.02. Revenue of $919.8M (+18.2% Y/Y) misses by $15.64M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, May 7, 12:05 AM Notable earnings before Tuesday’s open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC 2 Comments [Earnings]
Monday, May 6, 5:30 PM Notable earnings before Tuesday's open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC Comment! [Earnings]
Thursday, May 2, 3:34 PM Perrigo Company (PRGO) declares $0.09/share quarterly dividend, in line with previous. Forward yield 0.30%. For shareholders of record May 31. Payable June 18. Ex-div date May 29. (PR) Comment! [Dividends]
Monday, April 22, 10:22 AM Perrigo (PRGO +0.1%-) gets a slight boost this morning after JP Morgan ups the shares to Overweight and raised its price target from $120 to $132. The firm calls PRGO a "premium franchise" within its coverage universe, with Q3 potentially providing a number of positive catalysts to drive the shares higher, including the re-launch of its infant nutritional products and a rollout of its recently acquired store brand pet care offering. Comment! [Healthcare]
Monday, February 25, 3:32 PM Perrigo Company (PRGO +1.8%) trades higher after UBS upped the shares to Buy earlier today on valuation. The firm cites optimism over its generic testosterone gel 1%, which is a generic version of AbbVie's (ABBV -2%) AndroGel 1%, a treatment for adult males who have low or no testosterone. Comment! [Healthcare, On the Move]
Tuesday, February 5, 2:29 PM Perrigo (PRGO +1.6%) receives FDA approval to market its generic testosterone gel 1%. The product is a generic version of AbbVie's (ABBV +0.4%) AndroGel 1%, which is indicated to treat adult males who have low or no testosterone. Comment! [Healthcare, On the Move]
Friday, February 1, 11:08 AM Perrigo (PRGO +5.3%) trades higher after its FQ2 results easily beat estimates this morning. Net earnings rose 6.2% Y/Y as the store-brand pharmaceutical and nutritional-products maker recorded strong revenue growth from its consumer health-care business, although margins narrowed on higher costs. The company also says it's bought pet-health company Velcera for $160M in an all-cash deal it's billed as a "natural extension" to its Sergeant's pet care product line. Comment! [Healthcare, Earnings, On the Move, M&A]
Friday, February 1, 9:10 AM Premarket gainers: ADNC +30%. TSYS +15%. RAD +9%. CTRP +8%. EDAP +7%. ALU +6%. DELL +6%. VVUS +5%. PRGO +5%.
Losers: ECTE -35%. OTT -23%. LTM -16%. SDR -11%. OCZ -8%. CLSN -7%. ALKS -7%. NMM -6%. TLAB -5%. Comment! [On the Move]
Friday, February 1, 7:59 AM Perrigo (PRGO): FQ2 EPS of $1.36 beats by $0.05. Revenue of $883M beats by $1.16M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Friday, February 1, 12:05 AM Notable earnings before Friday’s open: AON, BEAM, BEN, BPO, CVX, HCLP, IR, LM, LYB, MAT, MRK, NOV, NS, NWL, PRGO, TSN, WETF, XOM Comment! [Earnings]
Thursday, January 31, 5:30 PM Notable earnings before Friday’s open: AON, BEAM, BEN, BPO, CVX, HCLP, IR, LM, LYB, MAT, MRK, NOV, NS, NWL, PRGO, TSN, WETF, XOM Comment! [Earnings]
Thursday, January 31, 2:56 PM Perrigo Company (PRGO) declares $0.09/share quarterly dividend, in line with previous. Forward yield 0.36%. For shareholders of record Mar. 01. Payable Mar. 19. Ex-div date Feb. 27. (PR) Comment! [Dividends]
Friday, December 28, 2012, 3:18 PM Perrigo Company (PRGO -0.8%) says it's acquired the remaining stake of privately held Cobrek Pharmaceuticals, in a deal worth approximately $45 million on a cash-free and debt-free basis. PRGO has had a collaborative agreement with the company since 2008, after buying an 18% interest to develop and market Cobrek's foam dosage form generic pharmaceutical products. Comment! [Healthcare, M&A]
Wednesday, November 28, 2012, 10:01 AM Cadence Pharmaceuticals (CADX +3.4%) and Perrigo (PRGO -1.3%) settle a lawsuit over Cadence's Ofirmev injection for reducing fever and pain. Under the deal, Perrigo has the first right of refusal to market any generic version of Ofirmev in the U.S. should Cadence decide to authorize such a version. Perrigo will also be allowed to launch a copycat drug in 2020. (PR) Comment! [Healthcare]